Miconazole
Active ingredient · 6 therapeutic classes
- Drug class
- Imidazole Derivatives
- Availability
- Over-the-counter
- Routes
- Topical, Vaginal
- Markets covered
- 3
- Products on record
- 25
Overview
Miconazole is an active pharmaceutical ingredient in the Imidazole Derivatives group (A07AC). The information below is compiled per regulator from the product labels on record, with direct links to the original documents.
Regulatory status by market
| Market | Regulator | Products | Last revision |
|---|---|---|---|
| GB United Kingdom | MHRA | 12 | April 24, 2026 |
| US United States | FDA | 11 | December 9, 2025 |
| CA Canada | Health Canada | 2 | March 22, 2025 |
GBUnited Kingdom· MHRA
12 products
Uses
Cutaneous administration for the treatment and prevention of athlete’s foot.
How to take
USUnited States· FDA
11 products
Uses
Uses cures most athlete's foot (linea pedis), ringworm (linea corporis) and jock itch (linea cruris) relieves symptoms of athlete's foot, including itching, burning and cracking
How to take
CACanada· Health Canada
2 products
2 products on record with this regulator. Detailed label text (uses, dosage, side effects) is being ingested — the original document is linked under Sources [3].
Drug interactions
Known interactions involving Miconazole. Select one for details. This list is informational and not a complete interaction checker.
Showing 240 of 351. Type above to find a specific drug.
Interaction data compiled from DDInter (academic, CC-BY). Severity classification only - this is not a complete interaction checker and not medical advice.
Sources & citations
- [1]MHRA (UK) · PL155130306 · revised March 13, 2026
- [2]FDA DailyMed · 0201dfee-75a3-4a… · revised October 14, 2024 [PDF]
- [3]Health Canada (DPD) · 02171775 · revised March 22, 2025
Information on this page is compiled from public regulatory records. Drugvu is not affiliated with any regulator or pharmaceutical manufacturer. This is not medical advice. Always consult a qualified healthcare professional.